Benchmark: Special Registrations for Telemedicine: DEA Proposed Rule Course

Take this benchmark to assess how much you would benefit from taking the course on Special Registrations for Telemedicine. In a few minutes, you’ll see where you stand on the intent of the proposed DEA framework, the operational changes it drives, and how ready you are to adopt it without disrupting care.

What you’ll get by taking this benchmark:
– Clarity on the rule’s purpose: balancing access to needed medications with safeguards against diversion.
– A sense of which special registration (clinician or platform) could fit your situation and why.
– Visibility into workflow shifts you may need: PDMP checks across jurisdictions, first-visit ID verification, EPCS, and audio–video encounter requirements.
– Insight into equity and access impacts (for rural patients, low-bandwidth settings, and vulnerable populations) and how to mitigate barriers.
– An understanding of platform governance and clinician oversight trade-offs, including prescribing analytics and reporting.
– Awareness of pharmacy implications, such as new aggregation and reporting expectations.
– Readiness to plan under a non-final rule: how to pilot, build flexibility, and engage in the public comment process.
– A quick gap analysis to help you decide if the full course will save you time, reduce compliance risk, and support safer, more equitable telemedicine prescribing.